169 related articles for article (PubMed ID: 37064087)
1. Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers.
Wang ZZ; Li XH; Wen XL; Wang N; Guo Y; Zhu X; Fu SH; Xiong FF; Bai J; Gao XL; Wang HJ
Front Oncol; 2023; 13():1130092. PubMed ID: 37064087
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer.
Wang N; He DN; Wu ZY; Zhu X; Wen XL; Li XH; Guo Y; Wang HJ; Wang ZZ
Front Genet; 2022; 13():916400. PubMed ID: 36061170
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
4. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications.
Asleh K; Riaz N; Nielsen TO
J Exp Clin Cancer Res; 2022 Sep; 41(1):265. PubMed ID: 36050786
[TBL] [Abstract][Full Text] [Related]
6. Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level.
Zhao Z; Jin T; Chen B; Dong Q; Liu M; Guo J; Song X; Li Y; Chen T; Han H; Liang H; Gu Y
Cell Cycle; 2023 Oct; 22(20):2229-2244. PubMed ID: 37974462
[TBL] [Abstract][Full Text] [Related]
7. Supervised graph contrastive learning for cancer subtype identification through multi-omics data integration.
Chen F; Peng W; Dai W; Wei S; Fu X; Liu L; Liu L
Health Inf Sci Syst; 2024 Dec; 12(1):12. PubMed ID: 38404715
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma.
Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L
Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209
[TBL] [Abstract][Full Text] [Related]
9. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
Front Immunol; 2022; 13():990143. PubMed ID: 36304471
[TBL] [Abstract][Full Text] [Related]
10. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
11. Attention-based GCN integrates multi-omics data for breast cancer subtype classification and patient-specific gene marker identification.
Guo H; Lv X; Li Y; Li M
Brief Funct Genomics; 2023 Nov; 22(5):463-474. PubMed ID: 37114942
[TBL] [Abstract][Full Text] [Related]
12. Delving into the Heterogeneity of Different Breast Cancer Subtypes and the Prognostic Models Utilizing scRNA-Seq and Bulk RNA-Seq.
Xu J; Qin S; Yi Y; Gao H; Liu X; Ma F; Guan M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077333
[TBL] [Abstract][Full Text] [Related]
13. Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer.
Zhang E; He J; Zhang H; Shan L; Wu H; Zhang M; Song Y
Front Genet; 2020; 11():595657. PubMed ID: 33281882
[TBL] [Abstract][Full Text] [Related]
14. Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.
Yu C; Zhou L; Zhang Q
Int Immunopharmacol; 2021 May; 94():107473. PubMed ID: 33611062
[TBL] [Abstract][Full Text] [Related]
15. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract][Full Text] [Related]
16. Immune depletion of the methylated phenotype of colon cancer is closely related to resistance to immune checkpoint inhibitors.
Zhong C; Xie T; Chen L; Zhong X; Li X; Cai X; Chen K; Lan S
Front Immunol; 2022; 13():983636. PubMed ID: 36159794
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.
Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS
Front Immunol; 2022; 13():861328. PubMed ID: 35479084
[TBL] [Abstract][Full Text] [Related]
18. Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.
Li C; Pan J; Luo J; Chen X
BMC Pulm Med; 2021 Nov; 21(1):389. PubMed ID: 34844602
[TBL] [Abstract][Full Text] [Related]
19. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
20. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
